期刊文献+

重组人干扰素Epsilon的表达纯化及生物学性质研究 被引量:7

Biological activities of recombinant human interferon Epsilon
原文传递
导出
摘要 目的表达纯化一种新型重组人干扰素Epsilon(rhIFNε155ser),并对它的生物学特性进行初步研究。方法人工合成rhIFNε155ser的全基因序列,并按照大肠埃希菌密码子嗜性作适当改造,然后构建到原核表达载体pBV220,在大肠埃希菌DH5α中表达。将表达的包涵体蛋白纯化复性后,对最终产物的抗病毒活性、细胞生长抑制活性和NK细胞刺激活性进行鉴定。同时,利用芯片技术,从基因的水平对rhIFNε155ser的生物机制进行初步的了解。结果rhIFNε155ser以包涵体的形式表达,经纯化蛋白纯度可达95%。复性后rhIFNε155ser在WISH抗VSV系统中的抗病毒活性可达6×105IU/mg。在100~1000pg/ml下rhIFNε155ser具有剂量依赖性的抗增殖活性,而NK细胞刺激活性无剂量依赖性。基因芯片扫描发现,22278个位点中,有283个基因显著上调,另外1894个显著下降。结论成功地表达了rhIFNε155ser,发现此IFN具有一定的抗病毒、抗增殖和NK细胞刺激活性。芯片技术可进一步拓展对IFN的功能研究。 Objective To construct a novel recombinant rhIFN-ε155ser and study its biological activities, Methods The v, hole sequence of rhIFN-ε was artificially synthesized and some codons were altered according to the preferred codon using of E. coli. The sequence was cloned into plasmid vector pBV220 to express in E. coli DH5α. After purification and re-folding of rhIFN-ε155ser inclusion body, the final product was tested for its biological activities, including anti-viral, anti-proliferative and NK cell enhancing activities. At the same time, by using DNA microarray bioehips, the gene expression patterns in the rhIFN-ε155ser and rhIFN-α2b treated cells were compared and analyzed. Results The re-built rhIFN-ε155ser sequence was expressed in E. coil as a form of inclusion body. After purified and re-folded, the rhIFN-ε155ser protein reached a purity of above 95%. The rhIFN-ε155ser protein had a specific anti-viral activity of about 6 × 10^5IU/ mg in WISH / VSV system. Its anti-proliferative activity and NK cell enhancing activities in vitro seemed to be lower than that of rhIFN-α2b. Data obtained from microarray bioehips indicated that there were 283 pieces increasing 2 folds and 1489 pieces decreasing 2 folds among totally 22 278 pieces of human genes were found in the rhIFN-ε155ser treated cells ; more changes in gene expression pattern were detected in the rhIFN-α treated cells. Conclusion A novel recombinant rhIFN-ε155ser was constructed, which belonged to type I interferon. The biological activities of rhIFN-ε155ser were compared with rhIFN-α2b. The changes of gene expression pattern in the interferon treated cells were detected, analyzed and discussed.
出处 《中华实验和临床病毒学杂志》 CAS CSCD 北大核心 2005年第3期227-231,共5页 Chinese Journal of Experimental and Clinical Virology
关键词 重组人干扰素 EPSILON 表达纯化 生物学性质 基因序列 基因芯片 Interferon type Ⅰ Inclusion bodies Protein renaturation Biological activity Gene chip
  • 相关文献

参考文献13

  • 1Gutterman JU. Cytokine therapeautics: lessons from interferon. Proc Natl Acad Sci U S A, 1994, 91:1198-1025. 被引量:1
  • 2Zymogenetics incorporation. Interferon-epsilon. Conklin DC, Grant FJ, Rixon MW, et al. Int CL:C07H 021/04 C12N 005/00 C12N005/10 C12N 001/20C12N001/15. US Patent 6329175. 2001-12-11. 被引量:1
  • 3Genetech incorporation. Human interferon-epsilon, a type Iinterferon. Chen J, Paul JG, Willian IW, et al. Int CL:C12N 015/20C0k 014/555 A61k 038/21. US Patent 6200780. 2001-03-13. 被引量:1
  • 4萨姆布鲁克J 弗里奇E F 曼尼阿蒂斯T 金冬雁 黎孟枫等译.分子克隆:第2版[M].北京: 科学出版社,1992.. 被引量:3
  • 5Familletti PC, Rubinstein S, Pestka S. A convenient and rapid cytopathic effect inhibition assay for interferon. Methods Enzymol,1981, 78: 387-394. 被引量:1
  • 6Amano K, Sago H, Uchikawa C, et al. Dosage-dependent overexpression of genes in the trisomic region of Ts1 Cje mouse model for Down syndrome. Hum Mol Genet, 2004, 13:1333-1340. 被引量:1
  • 7Mahmutovic S, Beslagic E. Significance of the interferon ( IFN ) in the therapy. Bosn J Basic Med Sci, 2004, 4: 42-44. 被引量:1
  • 8Kontsek P, Karayianni-Vasconcelos G, Kontsedova E. The human interferon system: characterization and classification after discovery of novel members. Acta virol, 2003, 47: 201-215. 被引量:1
  • 9Zhou A, Paranjape JM, Der SD, et al. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. Virology, 1999, 258: 435-440. 被引量:1
  • 10Alber D, Staeheli P. Partial inhibition of vesicular stomatitis virus by the interferon- induced human 9-27 protein. J Interferon Cytokine Res, 1996, 16: 375-380. 被引量:1

共引文献2

同被引文献73

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部